Correction to : Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
After publication of our article [1] the authors have notified us of two typos in the Trial status.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Trials - 21(2020), 1 vom: 30. März, Seite 296 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Yuqin [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.04.2020 published: Electronic ErratumFor: Trials. 2019 Dec 16;20(1):725. - PMID 31842950 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1186/s13063-020-04245-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM308143205 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM308143205 | ||
003 | DE-627 | ||
005 | 20231225131117.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13063-020-04245-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1027.xml |
035 | |a (DE-627)NLM308143205 | ||
035 | |a (NLM)32228673 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Yuqin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Correction to |b Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.04.2020 | ||
500 | |a published: Electronic | ||
500 | |a ErratumFor: Trials. 2019 Dec 16;20(1):725. - PMID 31842950 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a After publication of our article [1] the authors have notified us of two typos in the Trial status | ||
650 | 4 | |a Published Erratum | |
700 | 1 | |a He, Wenjun |e verfasserin |4 aut | |
700 | 1 | |a Ouyang, Haiping |e verfasserin |4 aut | |
700 | 1 | |a Liu, Chunli |e verfasserin |4 aut | |
700 | 1 | |a Hong, Cheng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Tao |e verfasserin |4 aut | |
700 | 1 | |a Yang, Kai |e verfasserin |4 aut | |
700 | 1 | |a Lu, Wenju |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Trials |d 2006 |g 21(2020), 1 vom: 30. März, Seite 296 |w (DE-627)NLM161320430 |x 1745-6215 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2020 |g number:1 |g day:30 |g month:03 |g pages:296 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13063-020-04245-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2020 |e 1 |b 30 |c 03 |h 296 |